Home Companies Shenzhen Kisshealth Biotechnology Co., Ltd

SARS-CoV-2 Antigen Rapid Detection Kit Immunofluorescence 5 Tests

Shenzhen Kisshealth Biotechnology Co., Ltd
Active Member

Contact Us

[China] country

Address: 301,Building B1,Compass Life Science Industrial Park, Julongshan Road A, Pingshan District, Shenzhen,China

Contact name:Meiko Wu

Inquir Now

Shenzhen Kisshealth Biotechnology Co., Ltd

SARS-CoV-2 Antigen Rapid Detection Kit Immunofluorescence 5 Tests

Country/Region china
City & Province shenzhen
Categories Dyestuff Intermediates
InquireNow

Product Details

SARS-CoV-2 Antigen Detection Kit(Immunofluorescence)

 

 

Product Information

Product nameSARS-CoV-2 Antigen Detection Kit(Immunofluorescence)
Main CompositionTest Cassette individually foil pouched with a desiccant, Sample Tube, with cap and antigen extraction buffer,Sampling swab, Instruction for use
Package1 Test/Kit
Keep temperature2-30℃
Shelf-life12 months
Place of OriginShenzhen China

 

 

Basis Information

The product is intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal (NP) and nasal swab, saliva specimens and superficial nasal swab directly from individuals who are suspected of COVID- 19 by their healthcare provider.

Results are to identify SARS-CoV-2 nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.

Negative results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient management. Negative results do not rule out COVID- 19 and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID- 19.The Antigen test kit is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings.

 

 

 

Hot Products

SARS-CoV-2 Antigen Control(H) Product Description Positive control of SARS-CoV-2 Antigen are clear ...
Covid-19 Antigen Control(H) Product Description Positive control of Covid-19 Antigen are clear and ...
SARS-CoV-2 Antigen Control(L) Product Description Negative control of SARS-CoV-2 Antigen are clear ...
Covid-19 Antigen Test Kit(Immunofluorescence) Product Information Product name SARS-CoV-2 Antigen ...
SARS-CoV-2 Antigen Detection Kit(Immunofluorescence) Product Information Product name SARS-CoV-2 ...
Positive control of SARS-CoV-2 Antigen Product Description Positive control of SARS-CoV-2 Antigen ...